Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas

Glioblastomas (GBM) are frequently resistant to immune checkpoint blockade therapy. Here the authors show that treatment with an agonistic anti-GITR antibody converts tumor infiltrating regulatory T cells to effector cells, overcoming resistance to PD1 blockade in preclinical models of GBM.

Guardado en:
Detalles Bibliográficos
Autores principales: Zohreh Amoozgar, Jonas Kloepper, Jun Ren, Rong En Tay, Samuel W. Kazer, Evgeny Kiner, Shanmugarajan Krishnan, Jessica M. Posada, Mitrajit Ghosh, Emilie Mamessier, Christina Wong, Gino B. Ferraro, Ana Batista, Nancy Wang, Mark Badeaux, Sylvie Roberge, Lei Xu, Peigen Huang, Alex K. Shalek, Dai Fukumura, Hye-Jung Kim, Rakesh K. Jain
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/1ab21691b67f4af6a88731fc02b3c2eb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1ab21691b67f4af6a88731fc02b3c2eb
record_format dspace
spelling oai:doaj.org-article:1ab21691b67f4af6a88731fc02b3c2eb2021-12-02T14:35:39ZTargeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas10.1038/s41467-021-22885-82041-1723https://doaj.org/article/1ab21691b67f4af6a88731fc02b3c2eb2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-22885-8https://doaj.org/toc/2041-1723Glioblastomas (GBM) are frequently resistant to immune checkpoint blockade therapy. Here the authors show that treatment with an agonistic anti-GITR antibody converts tumor infiltrating regulatory T cells to effector cells, overcoming resistance to PD1 blockade in preclinical models of GBM.Zohreh AmoozgarJonas KloepperJun RenRong En TaySamuel W. KazerEvgeny KinerShanmugarajan KrishnanJessica M. PosadaMitrajit GhoshEmilie MamessierChristina WongGino B. FerraroAna BatistaNancy WangMark BadeauxSylvie RobergeLei XuPeigen HuangAlex K. ShalekDai FukumuraHye-Jung KimRakesh K. JainNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Zohreh Amoozgar
Jonas Kloepper
Jun Ren
Rong En Tay
Samuel W. Kazer
Evgeny Kiner
Shanmugarajan Krishnan
Jessica M. Posada
Mitrajit Ghosh
Emilie Mamessier
Christina Wong
Gino B. Ferraro
Ana Batista
Nancy Wang
Mark Badeaux
Sylvie Roberge
Lei Xu
Peigen Huang
Alex K. Shalek
Dai Fukumura
Hye-Jung Kim
Rakesh K. Jain
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
description Glioblastomas (GBM) are frequently resistant to immune checkpoint blockade therapy. Here the authors show that treatment with an agonistic anti-GITR antibody converts tumor infiltrating regulatory T cells to effector cells, overcoming resistance to PD1 blockade in preclinical models of GBM.
format article
author Zohreh Amoozgar
Jonas Kloepper
Jun Ren
Rong En Tay
Samuel W. Kazer
Evgeny Kiner
Shanmugarajan Krishnan
Jessica M. Posada
Mitrajit Ghosh
Emilie Mamessier
Christina Wong
Gino B. Ferraro
Ana Batista
Nancy Wang
Mark Badeaux
Sylvie Roberge
Lei Xu
Peigen Huang
Alex K. Shalek
Dai Fukumura
Hye-Jung Kim
Rakesh K. Jain
author_facet Zohreh Amoozgar
Jonas Kloepper
Jun Ren
Rong En Tay
Samuel W. Kazer
Evgeny Kiner
Shanmugarajan Krishnan
Jessica M. Posada
Mitrajit Ghosh
Emilie Mamessier
Christina Wong
Gino B. Ferraro
Ana Batista
Nancy Wang
Mark Badeaux
Sylvie Roberge
Lei Xu
Peigen Huang
Alex K. Shalek
Dai Fukumura
Hye-Jung Kim
Rakesh K. Jain
author_sort Zohreh Amoozgar
title Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
title_short Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
title_full Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
title_fullStr Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
title_full_unstemmed Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
title_sort targeting treg cells with gitr activation alleviates resistance to immunotherapy in murine glioblastomas
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1ab21691b67f4af6a88731fc02b3c2eb
work_keys_str_mv AT zohrehamoozgar targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT jonaskloepper targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT junren targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT rongentay targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT samuelwkazer targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT evgenykiner targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT shanmugarajankrishnan targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT jessicamposada targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT mitrajitghosh targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT emiliemamessier targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT christinawong targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT ginobferraro targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT anabatista targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT nancywang targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT markbadeaux targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT sylvieroberge targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT leixu targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT peigenhuang targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT alexkshalek targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT daifukumura targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT hyejungkim targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
AT rakeshkjain targetingtregcellswithgitractivationalleviatesresistancetoimmunotherapyinmurineglioblastomas
_version_ 1718391057882808320